(Natural News) Pharmaceutical giant Eli Lilly has reneged on its promise to exempt employees with valid health or religious reasons from the company’s Wuhan coronavirus (COVID-19) vaccine mandate. Mandy Van Gorp lost her confidence in her employer of 18 years when the company denied her application for a medical exemption despite presenting a doctor’s note in support of her request. She […]

(Natural News) The Food and Drug Administration (FDA) gave Eli Lilly’s antibody drug emergency-use authorization on Monday, Nov. 9. Early data has strongly suggested that the pharmaceutical company’s antibody drug is effective at keeping people with mild to moderate cases of the Wuhan coronavirus (COVID-19) from needing to get admitted to a hospital. The FDA extended the emergency approval […]

(Natural News) American pharmaceutical firm Eli Lilly has agreed to supply the U.S. government with its experimental COVID-19 antibody medication. The company announced Oct. 28 that it will provide an initial 300,000 vials of the bamlanivimab antibody-drug amounting to $375 million, contingent on emergency use authorization (EUA) from the Food and Drug Administration (FDA). Eli […]

(Natural News) British pharmaceutical company AstraZeneca has commenced late-stage trials for its COVID-19 antibody drug. In an Oct. 9 statement, the company said that two tests for the AZD7442 long-acting antibody drug, involving 6,000 adult participants worldwide, will look at the medication’s ability to prevent COVID-19 symptoms. A subsequent trial to observe AZD7442’s use as a […]

(Natural News) A new collaborative report by STAT and the National Institute on Money and Politics provides a first-of-its-kind analysis of the drug industry’s influence on state representatives. (Article by Jeremy Loffredo republished from ChildrensHealthDefense.org) The report also makes it easy for citizens to find out how much cash the industry spent in their state, and which […]

(Natural News) Eli Lilly & Company are halting the enrollment of participants in a clinical trial of its antibody treatment for the Wuhan coronavirus (COVID-19) due to safety concerns. According to company spokeswoman Molly McCully, an independent data and safety monitoring board (DSMB) had recommended pausing enrollment in the U.S. government-sponsored trials. Lilly, however, did not say […]

(Natural News) Trump Derangement Syndrome (TDS) is creeping its way into America’s criminal justice system, as yet another questionable judge has ruled against the president and in favor of the pharmaceutical industry as it pertains to drug price transparency. According to reports, United States District Court Judge Amit P. Mehta of Washington, D.C., recently decided […]

(Natural News) There’s a new chief in town, Alex Azar, who, should he receive confirmation from Congress, will soon take over as head of the United States Department of Health and Human Services (HHS). But not everyone is happy with this decision because Azar is the former president of Lilly USA, the American arm of […]

(Natural News) What investors had hoped would build into yet another 2.68 percent dividend yield for pharmaceutical behemoth Eli Lilly has turned into a massive financial letdown after trials of solanezumab, a supposedly promising experimental drug for Alzheimer’s disease and other forms of dementia, showed less than favorable efficacy in the latest clinical trials. Reports […]